The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Genetic Modifiers of Lung Disease in Cystic Fibrosis
Open accessAbstract
BACKGROUND: Polymorphisms in genes other than the cystic fibrosis transmembrane conductance regulator (CFTR) gene may modify the severity of pulmonary disease in patients with cystic fibrosis. METHODS: We performed two studies with different patient samples. We first tested 808 patients who were homozygous for the DeltaF508 mutation and were classified as having either severe or mild lung disease, as defined by the lowest or highest quartile of forced expiratory volume in one second (FEV1), respectively, for age. We genotyped 16 polymorphisms in 10 genes reported by others as modifiers of disease severity in cystic fibrosis and tested for an association in patients with severe disease (263 patients) or mild disease (545). In the replication (second) study, we tested 498 patients, with various CFTR genotypes and a range of FEV1 values, for an association of the TGFbeta1 codon 10 CC genotype with low FEV1. RESULTS: In the initial study, significant allelic and genotypic associations with phenotype were seen only for TGFbeta1 (the gene encoding transforming growth factor beta1), particularly the -509 and codon 10 polymorphisms (with P values obtained with the use of Fisher's exact test and logistic regression ranging from 0.006 to 0.0002). The odds ratio was about 2.2 for the highest-risk TGFbeta1 genotype (codon 10 CC) in association with the phenotype for severe lung disease. The replication study confirmed the association of the TGFbeta1 codon 10 CC genotype with more severe lung disease in comparisons with the use of dichotomized FEV1 for severity status (P=0.0002) and FEV1 values directly (P=0.02). CONCLUSIONS: Genetic variation in the 5' end of TGFbeta1 or a nearby upstream region modifies disease severity in cystic fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
Hosmer, D. W., & Lemeshow, S. (2000) · doi:10.1002/0471722146 · Cited by 20,302
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
The International HapMap Project
†The International HapMap Consortium, Genotyping centres: Baylor College of Medicine and ParAllele BioScience, Gibbs, R. A., Belmont, J. W., Hardenbol, P., Willis, T. D., Yu, F., Chinese HapMap Consortium, Yang, H., Ch'ang, L.-Y., et al. (2003) · Nature · doi:10.1038/nature02168 · Cited by 6,057
Webb, A. K. (2006) · Cited by 4,369
Role of Transforming Growth Factor β in Human Disease
Blobe, G. C., Schiemann, W. P., & Lodish, H. F. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421807 · Cited by 2,427
Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population.
(1995) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a040269 · Cited by 1,950
Genetic data analysis II: methods for discrete population genetic data
(1996) · Choice Reviews Online · doi:10.5860/choice.34-2150 · Cited by 1,630
Population stratification and spurious allelic association
Cardon, L. R., & Palmer, L. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12520-2 · Cited by 1,204
Prediction of mortality in patients with cystic fibrosis
Kerem, E., Reisman, J., Corey, M., Canny, G. J., & Levison, H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204303261804 · Cited by 993
Self-citationGOLD—Graphical Overview of Linkage Disequilibrium
Abecasis, G. R., & Cookson, W. O. C. (2000) · Bioinformatics · doi:10.1093/bioinformatics/16.2.182 · Cited by 773
Genetic control of the circulating concentration of transforming growth factor type beta1
Grainger, D. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.1.93 · Cited by 755
Kerem, E., Corey, M., Kerem, B.-S., Rommens, J., Markiewicz, D., Levison, H., Tsui, L.-C., & Durie, P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011293232203 · Cited by 728
Self-citationLoss of integrin αvβ6-mediated TGF-β activation causes Mmp12-dependent emphysema
Morris, D. G., Huang, X., Kaminski, N., Wang, Y., Shapiro, S. D., Dolganov, G., Glick, A., & Sheppard, D. (2003) · Nature · doi:10.1038/nature01413 · Cited by 500
Qin, Z. S., Niu, T., & Liu, J. S. (2002) · The American Journal of Human Genetics · doi:10.1086/344207 · Cited by 489
Garred, P., Pressler, T., Madsen, H. O., Frederiksen, B., Svejgaard, A., Høiby, N., Schwartz, M., & Koch, C. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6861 · Cited by 439
Dunning, A. M., Ellis, P. D., McBride, S. E., Kirschenlohr, H. L., Healey, C. S., Kemp, P. R., Luben, R., Chang-Claude, J. C., Mannermaa, A., Kataja, V. V., et al. (2003) · PubMed · Cited by 370
Detecting Marker-Disease Association by Testing for Hardy-Weinberg Disequilibrium at a Marker Locus
Nielsen, D. M., Ehm, M. G., & Weir, B. S. (1998) · The American Journal of Human Genetics · doi:10.1086/302114 · Cited by 366
Yamada, Y., Miyauchi, A., Goto, J., Takagi, Y., Okuizumi, H., Kanematsu, M., Hase, M., Takai, H., Harada, A., & Ikeda, K. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.10.1569 · Cited by 321
Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis
Corey, M., Edwards, L., Levison, H., & Knowles, M. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70025-8 · Cited by 283
Self-citationSuthanthiran, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050420897 · Cited by 281
Sterner-Kock, A., Thorey, I. S., Koli, K., Wempe, F., Otte, J., Bangsow, T., Kuhlmeier, K., Kirchner, T., Jin, S., Keski-Oja, J., et al. (2002) · Genes & Development · doi:10.1101/gad.229102 · Cited by 256
Transforming Growth Factor-β 1 Promoter Polymorphism C–509T Is Associated with Asthma
Silverman, E. S., Palmer, L. J., Subramaniam, V., Hallock, A., Mathew, S., Vallone, J., Faffe, D. S., Shikanai, T., Raby, B. A., Weiss, S. T., et al. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200307-973oc · Cited by 244
Celedon, J. C. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh171 · Cited by 234
TGF-beta 1 genotype and accelerated decline in lung function of patients with cystic fibrosis
Arkwright, P. D. (2000) · Thorax · doi:10.1136/thorax.55.6.459 · Cited by 219
TGFβ1 allele association with asthma severity
Pulleyn, L. J., Newton, R., Adcock, I. M., & Barnes, P. J. (2001) · Human Genetics · doi:10.1007/s00439-001-0617-y · Cited by 178
Xaubet, A., Marin-Arguedas, A., Lario, S., Ancochea, J., Morell, F., Ruiz-Manzano, J., Rodriguez-Becerra, E., Rodriguez-Arias, J. M., Iñigo, P., Sanz, S., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200210-1165oc · Cited by 176
TGFβ signaling in health and disease
Akhurst, R. J. (2004) · Nature Genetics · doi:10.1038/ng0804-790 · Cited by 154
Bronsveld, I., Mekus, F., Bijman, J., Ballmann, M., de Jonge, H. R., Laabs, U., Halley, D. J. J., Ellemunter, H., Mastella, G., Thomas, S., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12108 · Cited by 148
Transforming growth factor- 1 genotype and susceptibility to chronic obstructive pulmonary disease
Wu, L. (2004) · Thorax · doi:10.1136/thorax.2003.005769 · Cited by 142
SCHLUCHTER, M. D., Konstan, M. W., & Davis, P. B. (2002) · Statistics in Medicine · doi:10.1002/sim.1104 · Cited by 110
Self-citationБаранов, В. С., Ivaschenko, T. E., Bakay, B., Aseev, M. V., Belotserkovskaya, R., Баранов, В. С., Malet, P., Perriot, J., Mouraire, P., Baskakov, V. N., et al. (1996) · Human Genetics · doi:10.1007/bf02267078 · Cited by 106
Gabolde, M., GUILLOUD-BATAILLE, M., Feingold, J., & Besmond, C. (1999) · BMJ · doi:10.1136/bmj.319.7218.1166 · Cited by 103
Carlsson, M., Sjöholm, A. G., Eriksson, L. T., Thiel, S., Jensenius, J. C., Segelmark, M., & Truedsson, L. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02690.x · Cited by 77
Impaired pulmonary status in cystic fibrosis adults with two mutatedMBL-2alleles
Davies, J. C., TURNER, M. W., Klein, N. J., & and the London MBL CF Study Group The London MBL CF Study Group: C. Booth, M. J. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00055404 · Cited by 73
Arkwright, P. D., Pravica, V., Geraghty, P. J., Super, M., Webb, A. K., Schwarz, M. J., & Hutchinson, I. V. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200204-364oc · Cited by 67
beta2 adrenoceptor gene polymorphisms in cystic fibrosis lung disease.
Büscher, R., Eilmes, K., Grasemann, H., Torres, B., Knauer, N., Sroka, K., Insel, P. A., & Ratjen, F. A. (2002) · Pharmacogenetics · doi:10.1097/00008571-200207000-00002 · Cited by 63
Döring, G., Krogh‐Johansen, H., Weidinger, S., & Høiby, N. (1994) · Pediatric Pulmonology · doi:10.1002/ppul.1950180104 · Cited by 61
Polymorphisms in the mannose binding lectin gene affect the cystic fibrosis pulmonary phenotype
Yarden, J., Radojkovic, D., Boeck, K. D., Macek, M., Zemkova, D., Vavrova, V., VLIETINCK, R. F., Cassiman, J.-J., & Cuppens, H. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.017947 · Cited by 61
Alpha1-antitrypsin deficiency alleles and the Taq-I G-->A allele in cystic fibrosis lung disease
Mahadeva, R., Westerbeek, R. C., Perry, D. J., Lovegrove, J., Whitehouse, D. B., Carroll, N., Ross-Russell, R. I., Webb, A. K., Bilton, D., & Lomas, D. A. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.11040873 · Cited by 59
α1-Antitrypsin Deficiency Alleles in Cystic Fibrosis Lung Disease
Frangolias, D. D., Ruan, J., Wilcox, P. J., Davidson, A. G. F., Wong, L. T. K., Berthiaume, Y., Hennessey, R., Freitag, A. P., Pedder, L., Corey, M. L., et al. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2002-0271oc · Cited by 51
Self-citationHenry, M. T., Cave, S., Rendall, J. C., O'CONNOR, C. M., Morgan, K., FitzGerald, M. X., & Kalsheker, N. A. (2001) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200623 · Cited by 42
Cited by
Carnitine—metabolism and functions
Bremer, J. (1983) · Physiological Reviews · doi:10.1152/physrev.1983.63.4.1420 · Cited by 1,666
O'Sullivan, B. P., & Freedman, S. D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60327-5 · Cited by 1,320
Farrell, P. M., Rosenstein, B. J., White, T. B., Accurso, F. J., Castellani, C., Cutting, G. R., Durie, P. R., LeGrys, V. A., Massie, J., Parad, R. B., et al. (2008) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2008.05.005 · Cited by 1,094
Self-citationCystic fibrosis genetics: from molecular understanding to clinical application
Cutting, G. R. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3849 · Cited by 965
Cooper, D. N., Krawczak, M., Polychronakos, C., Tyler-Smith, C., & Kehrer-Sawatzki, H. (2013) · Human Genetics · doi:10.1007/s00439-013-1331-2 · Cited by 645
Metadata
- Authors
- Drumm, M. L., Konstan, M. W., Schluchter, M. D., Handler, A., Pace, R., Zou, F., Zariwala, M., Fargo, D., Xu, A., Dunn, J. M., Darrah, R. J., Dorfman, R., Sandford, A. J., Corey, M., Zielenski, J., Durie, P., Goddard, K., Yankaskas, J. R., Wright, F. A., & Knowles, M. R.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-10-06
- Volume
- 353
- Issue
- 14
- Pages
- 1443-1453
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1979451256
- Cited by
- 504
- References
- 42
- FWCI
- 31.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.